This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Sancilio & Company, Inc.
Drug Names(s): SC-404, docosahexaenoic acid (DHA)
Description: SC404 is a reformulation of docosahexaenoic acid, DHA, under development by Sancilio using its Advanced Lipid Technologies (ALT) lipophilic delivery system.
Additional information available to subscribers only: